Treatment with homoharringtonine and cytarabine in patients with high risk acute myelogenous leukemia (AML).

被引：0
|
作者：
Chang, Naibai [1 ]
Wei, Jianping [1 ]
Zhao, Shengming [1 ]
Liu, Hui [1 ]
Fan, Yun [1 ]
Li, Jiangtao [1 ]
Xu, Xiaodong [1 ]
Gu, Xichun [1 ]
机构：
[1] Beijing Union Med Coll Hosp, Dept Hematol, Beijing, Peoples R China
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4555
引用
收藏
页码：218B / 218B
页数：1
相关论文
共 50 条
  • [21] BIOLOGIC AND TREATMENT DETERMINANTS IN CURABILITY OF ACUTE MYELOGENOUS LEUKEMIA (AML)
    KEATING, MJ
    LEUKEMIA RESEARCH, 1986, 10 (01) : 86 - 86
  • [22] Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes
    Tsimberidou, A
    Estey, E
    Cortes, J
    Thomas, D
    Faderl, S
    Verstovsek, S
    Garcia-Manero, G
    Keating, M
    Albitar, M
    O'Brien, S
    Kantarjian, H
    Giles, F
    CANCER, 2003, 97 (06) : 1481 - 1487
  • [23] CHILDHOOD ACUTE MYELOGENOUS LEUKEMIA (AML) REFRACTORY TO ANTHRACYCLINE CYTARABINE (ARA-C) THERAPIES
    KALWINSKY, D
    LOOK, AT
    MIRRO, J
    DAHL, GV
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 193 - 193
  • [24] CHEMOIMMUNOTHERAPY IN ACUTE MYELOGENOUS LEUKEMIA (AML)
    GALE, RP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 139 - 139
  • [25] INCREASED RISK OF ACUTE MYELOGENOUS LEUKEMIA (AML) AND CHRONIC MYELOGENOUS LEUKEMIA (CML) IN A COUNTY OF HESSE, GERMANY
    KOLB, G
    BECKER, N
    SCHELLER, S
    ZUGMAIER, G
    PRALLE, H
    WAHRENDORF, J
    HAVEMANN, K
    SOZIAL-UND PRAVENTIVMEDIZIN, 1993, 38 (04): : 190 - 195
  • [26] HIGH-DOSE CYTARABINE (HD-ARA-C) IN REFRACTORY AND RELAPSED ADULT ACUTE MYELOGENOUS LEUKEMIA (AML)
    HOFELER, H
    ANDERS, CU
    POPESCU, O
    HOFFKEN, K
    SCHMIDT, CG
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 209 - 209
  • [27] TREATMENT OF DENOVO ACUTE MYELOGENOUS LEUKEMIA IN ELDERLY PATIENTS USING LOW-DOSE CYTARABINE
    TILLY, H
    CASTAIGNE, S
    SIGAUX, F
    DEGOS, L
    PRESSE MEDICALE, 1985, 14 (15): : 827 - 831
  • [28] Mylotarg combined with topotecan and cytarabine in patients with refractory acute myelogenous leukemia
    Jorge Cortes
    Apostolia M. Tsimberidou
    Ricardo Alvarez
    Deborah Thomas
    Miloslav Beran
    Hagop Kantarjian
    Elihu Estey
    Francis J. Giles
    Cancer Chemotherapy and Pharmacology, 2002, 50 : 497 - 500
  • [29] Mylotarg combined with topotecan and cytarabine in patients with refractory acute myelogenous leukemia
    Cortes, J
    Tsimberidou, AM
    Alvarez, R
    Thomas, D
    Beran, ML
    Kantarjian, H
    Estey, E
    Giles, FJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (06) : 497 - 500
  • [30] Acyclovir bioavailability in patients with acute myelogenous leukemia treated with daunorubicin and cytarabine
    Sitar, Daniel S.
    Aoki, Fred Y.
    Bow, Eric J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (08): : 995 - 998
12345